Neonatal group B streptococcus infection in Taiwan: An increasing trend

Acta Paediatrica Taiwanica

Volumn 43, Issue 6, 2002, Pages 312-

  Huang, Fu Yuan ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; MENINGITIS VACCINE; PENICILLIN G;

ANTIBIOTIC PROPHYLAXIS; BACTERIUM ISOLATION; CLINICAL FEATURE; DOSE RESPONSE; DRUG INDICATION; EDITORIAL; HUMAN; MENINGITIS; MINIMUM INHIBITORY CONCENTRATION; NEWBORN SEPSIS; PRACTICE GUIDELINE; PREVALENCE; SEROTYPE; STREPTOCOCCUS AGALACTIAE; TAIWAN; TREATMENT OUTCOME;

HUMANS; INFANT, NEWBORN; PENICILLIN RESISTANCE; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; TAIWAN;

EID: 0036876927     PISSN: 16088115     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (5)

1. Chang Chien HY, Chiu NC, Li WC, et al. Characteristics of neonatal bacterial meningitis in a teaching hospital in Taiwan from 1984-1997. J Microbiol Immunol Infect 2000; 33:100-4.
2. Harrison LH, Elliot JA, Dwyer DM, et al. Serotype distribution of invasive group B streptococcal isolates in the Maryland: implication for vaccine formulations. J Infect Dis 1998; 177:998-1002.
3. Schuchat A, Whitney C, Zangwill K. Prevention of perinatal group B streptococcal disease: a public health perspective. MMWR 1996; 45:1-24.
4. Lin FY, Azimi PH, Weisman LE, et al. Antibiotics susceptibility profiles for group B streptococci isolated from neonates. Clin Infect Dis 2000; 31:76-9.
5. Edwards MS, Baker CJ. Update on Group B Streptococcus. In: Hansen TN, McIntosh N, eds. Current topics in neonatology. Philadelphia: WB Sanders, 2000; 4:199-213.